Professor, Cell Biology and Member of Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Dr. Theodore J. Lampidis is a Professor of Cell Biology at the Miller School of Medicine and Sylvester Comprehensive Cancer Center. His lab is internationally recognized as a leader in investigating cancer glucose metabolism and for developing 2-deoxy-D-glucose (2-DG) as a universal anti-cancer treatment. His work has gone from the lab to the clinic resulting in an investigator-initiated Phase I clinical trial. His lab’s uncovering the potential of 2-DG to not only mimic glucose but also act as a mannose analog has led to a new understanding of how viral infections can be treated with 2-DG. His findings in cancer and virology contributed to the Indian government’s approval of 2-DG being used in COVID patients. He was awarded a United States Congressional Record in honor of his work developing 2-DG as a non-toxic cancer treatment.
Dr. Lampidis graduated from Brooklyn College with a Bachelor of Science degree majoring in chemistry and received his master’s degree in medical microbiology from New York University. He received his Ph.D. in immunology and microbiology from the University of Miami and completed his postdoctoral training at the Harvard School of Public Health and Dana Farber Cancer Institute. He came back to Miami and joined the Department of Oncology at the Sylvester Comprehensive Cancer Center at University of Miami as an Assistant Professor in 1983 and attained the rank of tenured Professor in 1995.
He has had an outstanding record of almost continuous NIH/NCI funding for his work in cancer, has published over 100 peer-reviewed articles and has been an invited speaker at many prestigious cancer institutes throughout the world, including: Oxford University in England; The Max Planck Institute in Munich, Germany; The Paul Brousse Institute in Villejuif, France; Wolfson Institute for Biomedical Research, University College London, England; Harvard Medical School in Boston; The Albert Einstein Cancer Center and Memorial Sloan Kettering Cancer Center in New York; The MD Anderson Cancer Center in Houston, and a host of others.
